Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 253.80
Bid: 253.40
Ask: 253.80
Change: -1.20 (-0.47%)
Spread: 0.40 (0.158%)
Open: 252.00
High: 257.20
Low: 250.80
Prev. Close: 255.00
EMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

27 Sep 2018 17:36

RNS Number : 2323C
Man Group plc
27 September 2018
 

Transactions in own shares

 

Man Group plc (the "Company") announces that it has purchased the following number of its ordinary shares of 3 3/7 US cents on the London Stock Exchange through J.P. Morgan Securities plc as part of its US$100 million share repurchase programme announced on 12 April 2018.

 

Date of purchase:

27 September 2018

 

Number of ordinary shares purchased:

324,363

 

Time of transaction:

08:00 to 16:30

 

Highest price per share:

178.6000

 

Lowest price per share:

176.3500

 

Weighted average price per share:

177.4845

 

 

The Company intends to hold the purchased shares in treasury. Following the purchase and settlement of these shares, the Company will hold 25,999,502 of its ordinary shares in treasury and will have 1,584,142,811 ordinary shares in issue (excluding treasury shares).

 

Since the commencement of the share repurchase programme, the Company has repurchased 35,781,007 ordinary shares in aggregate at a weighted average price of 177.8047 pence per share.

 

All transactions under this programme will be published on the Company's website (www.man.com) on a weekly basis.

 

Enquiries

 

Fiona Smart

 

Head of Investor Relations

 

+44 20 7144 2030

 

fiona.smart@man.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSPGUGABUPRGAM
Date   Source Headline
28th Sep 20216:07 pmRNSTransaction in Own Shares
27th Sep 20215:50 pmRNSTransaction in Own Shares
24th Sep 20216:06 pmRNSTransaction in Own Shares
23rd Sep 20215:49 pmRNSTransaction in Own Shares
22nd Sep 202110:13 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
22nd Sep 202110:06 amGNWMan Group PLC : Form 8.3 - John Laing Group plc
21st Sep 20215:47 pmRNSTransaction in Own Shares
21st Sep 20219:19 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Sep 20215:41 pmRNSTransaction in Own Shares
17th Sep 20215:54 pmRNSTransaction in Own Shares
17th Sep 20213:00 pmRNSDirectorate Change
16th Sep 20215:52 pmRNSTransaction in Own Shares
15th Sep 20216:16 pmRNSTransaction in Own Shares
15th Sep 202111:14 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
14th Sep 20215:52 pmRNSTransaction in Own Shares
14th Sep 20211:56 pmRNSMan Group PLC : Form 8.3 - Strongbridge biopharma plc
13th Sep 20215:51 pmRNSTransaction in Own Shares
13th Sep 202112:15 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
13th Sep 202112:06 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
10th Sep 20215:55 pmRNSTransaction in Own Shares
10th Sep 20217:21 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
9th Sep 20215:58 pmRNSTransaction in Own Shares
9th Sep 202111:40 amRNSDirector/PDMR Shareholding
9th Sep 20216:56 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
8th Sep 20215:53 pmRNSTransaction in Own Shares
8th Sep 20214:25 pmRNSDirector/PDMR Shareholding
8th Sep 20217:15 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
7th Sep 20215:54 pmRNSTransaction in Own Shares
3rd Sep 20215:47 pmRNSTransaction in Own Shares
3rd Sep 20217:58 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
3rd Sep 20217:02 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
2nd Sep 20215:56 pmRNSTransaction in Own Shares
2nd Sep 20216:59 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Sep 20216:48 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
1st Sep 20215:54 pmRNSTransaction in Own Shares
1st Sep 20217:21 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
1st Sep 20217:06 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
1st Sep 20217:00 amRNSTotal Voting Rights
31st Aug 20216:02 pmRNSTransaction in Own Shares
31st Aug 20217:47 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
31st Aug 20217:22 amGNWMan Group PLC : Form 8.3 - Stonebridge Biopharma plc
30th Aug 20217:22 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
27th Aug 20215:41 pmRNSTransaction in Own Shares
27th Aug 20218:20 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
26th Aug 20215:35 pmRNSTransaction in Own Shares
26th Aug 202110:18 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
25th Aug 20215:47 pmRNSTransaction in Own Shares
25th Aug 202112:59 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
25th Aug 202112:54 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
24th Aug 20215:45 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.